Quick Takeaways
- Benjamin Hickey has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,125,913.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Benjamin Hickey and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BMY, CELG-RI | BRISTOL MYERS SQUIBB CO | President, RayzeBio Org. | $2,097,565 | -$3,702 | -0.18% | 10 Mar 2026 |
| MURA | Mural Oncology plc | Director | $28,348 | 05 Dec 2025 | ||
| MRTX | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | 23 Jan 2024 | |||
| SURF | Surface Oncology, Inc. | Director | 08 Jun 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|